These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9626227)

  • 1. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.
    McGinn CJ; Ten Haken RK; Ensminger WD; Walker S; Wang S; Lawrence TS
    J Clin Oncol; 1998 Jun; 16(6):2246-52. PubMed ID: 9626227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
    Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.
    Strigari L; Sciuto R; Rea S; Carpanese L; Pizzi G; Soriani A; Iaccarino G; Benassi M; Ettorre GM; Maini CL
    J Nucl Med; 2010 Sep; 51(9):1377-85. PubMed ID: 20720056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.
    Dawson LA; McGinn CJ; Normolle D; Ten Haken RK; Walker S; Ensminger W; Lawrence TS
    J Clin Oncol; 2000 Jun; 18(11):2210-8. PubMed ID: 10829040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.
    Robertson JM; Lawrence TS; Walker S; Kessler ML; Andrews JC; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):445-50. PubMed ID: 7751185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.
    Shilkrut M; Sapir E; Hanasoge S; Schipper MJ; Normolle DP; Ben-Josef E; Ensminger W; Lawrence TS; Feng M
    Am J Clin Oncol; 2018 Apr; 41(4):326-331. PubMed ID: 26886946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
    Rosenzweig KE; Mychalczak B; Fuks Z; Hanley J; Burman C; Ling CC; Armstrong J; Ginsberg R; Kris MG; Raben A; Leibel S
    Cancer J; 2000; 6(2):82-7. PubMed ID: 11069224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer.
    Prayongrat A; Srimaneekarn N; Sriswasdi S; Ito YM; Katoh N; Tamura M; Dekura Y; Toramatsu C; Khorprasert C; Amornwichet N; Alisanant P; Hirata Y; Hayter A; Shirato H; Shimizu S; Kobashi K
    J Radiat Res; 2021 May; 62(3):483-493. PubMed ID: 33899102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapolation of normal tissue complication probability for different fractionations in liver irradiation.
    Tai A; Erickson B; Li XA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):283-9. PubMed ID: 19289259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients.
    Prayongrat A; Kobashi K; Ito YM; Katoh N; Tamura M; Dekura Y; Toramatsu C; Khorprasert C; Amornwichet N; Alisanant P; Shirato H; Shimizu S
    Radiother Oncol; 2019 Jun; 135():100-106. PubMed ID: 31015154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial irradiation of the liver.
    Dawson LA; Ten Haken RK; Lawrence TS
    Semin Radiat Oncol; 2001 Jul; 11(3):240-6. PubMed ID: 11447581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer.
    Mohiuddin M; Chen E; Ahmad N
    J Clin Oncol; 1996 Mar; 14(3):722-8. PubMed ID: 8622017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer.
    Lawrence TS; Kessler ML; Robertson JM
    Oncology (Williston Park); 1993 Oct; 7(10):51-7; discussion 57-8, 63. PubMed ID: 8251308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformal chemoradiation for primary and metastatic liver malignancies.
    Dawson LA; McGinn CJ; Lawrence TS
    Semin Surg Oncol; 2003; 21(4):249-55. PubMed ID: 14648782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.